Prevalence, risk factors and clinical characteristics of lipohypertrophy in insulin-treated patients with diabetes

Phase 4

Completed

• Conditions: - Prevalence of insulin- induced lipohypertrophy- Severity of insulin- Related factors to development of insulin- induced lipohypertrophy; Insulin, Lipohypertrophy, Diabetes Mellitus

• Registration Number: TCTR20190707003
• Lead Sponsor: Theptarin Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-05-01
• Study Start: 2019-07-07
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

-Insulin treated DM patients (both T1DM and T2DM) who are regularly F/U at Theptarin Hospital at least 3 times per year
-Continuation of insulin treatment at least 6 months

Exclusion Criteria

- Non-insulin treated DM patients
- Use of insulin less than 6 months
- Irregular or lost to F/U patients

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The presence of lipohypertrophy 9 months Percentage

Secondary Outcome Measures

Name	Time	Method
Severity of Lipohypertrophy, Patients' awareness of Lipohypertrophy 9 months Grading of Lipohypertrophy based on observation and palpation technique, Awareness Questionnaire